Abstract
Introduction

Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disorder, characterized by distinct neuropathological lesions. These include extracellular deposits of ␤ amyloid (A␤) in senile plaques, accumulation of intraneuronal neurofibrillary tangles and profound neuronal death (reviewed in [1-3]). Clinical symptoms include the inability to encode new memories as well as cognitive and behavioural impairments
. Most cases of the disease are sporadic, with advancing age being the major risk factor for developing AD. The prevalence of AD rises exponentially with age from approximately 1% at 65 years to 40% after the age of 90 [5-7] . Furthermore, individuals harbouring the ⑀4 allele of apolipoprotein E have an increased risk for developing sporadic, late-onset AD [8, 9] . A small fraction of AD patients, however, have an inherited autosomal dominant form of the disease. These hereditary AD forms are characterized by an earlier onset and are typically caused by mutations in genes encoding human amyloid precursor protein (APP) or presenilin 1 (PS1) and presenilin 2 (PS2) [1, 3, 10] . The presenilins are the part of the ␥-secretase complex involved in the synthesis of A␤, which is derived from APP by sequential enzymatic cleavage by ␤-APP cleaving enzyme and ␥-secretase complex [10, 11] .
Expressed in transgenic mice, APP and presenilins with familial mutations allow various aspects of AD neuropathology to be modelled. The mutant mice develop senile plaques and neurofibrillary tangles, exhibit dysregulation of the intracellular Ca 2ϩ
homeostasis, brain inflammatory response and memory impairment. However, they do not recapitulate the widespread neuronal loss seen in humans [12] .
Accumulation of A␤ plays a crucial role in the genesis of AD [2, 3, 13] . Among the three forms of A␤ (A␤38, A␤40, A␤42), A␤42 seems to be the most important for the pathogenesis of the disease because it more easily aggregates into oligomers and amyloid fibrils [14] . Mounting evidence suggests that the soluble oligomers (presumably dimers and trimers) are the neurotoxic species in AD [13] . Indeed, naturally secreted small A␤ oligomers have been shown to inhibit long-term potentiation (LTP, [15] ), the electrophysiological correlate of learning and memory [13, 16] and to induce a loss of hippocampal synapses [17] [18] [19] . Moreover, similar effects were caused by oligomers extracted from the cerebral cortex of AD patients. In wild-type rodents, human oligomers inhibited LTP, enhanced long-term depression, reduced dendritic spine density and interfered with the memory of a learned behaviour [20] . Interestingly, the soluble A␤ dodecamer (A␤*56, [21] ) also seems to impair memory. Thus [10, 13] . Another source of A␤ accumulation within the brain is the imbalance between its production and clearance caused by impaired degradation of A␤ (reviewed in [22, 23] ). A␤ is cleaved by several proteases, including neprilysin [24, 25] , insulin-degrading enzyme [25] , endothelin-converting enzyme [26] , plasmin [27] and cathepsin B [28] . Neprilysin [25, 29] and cathepsin B [28] overexpression in transgenic mice reduces total A␤ levels and plaque deposition, whereas their pharmacological blockade or genetic ablation increases A␤ load [28, 30, 31] . The activity/expression of neprilysin is down-regulated with aging and at the early stage of AD [28, [32] [33] [34] [91] . Compared to wild-type mice, [Ca 2ϩ ]i was globally increased in the astrocytic network of 6-to 8-month-old mutant mice (yellow-green astrocytes in Fig. 2) . Furthermore, astrocytes in mutant mice exhibited a significant increase in spontaneous activity (see also [92] 
AD-mediated hyperactivity and synaptic network dysfunction
The observation that amyloid plaques in vivo are surrounded by hyperactive cells [90] came as a surprise because of the wealth of data showing that AD is associated with synaptic dismantling and 'synaptic failure' [93] . Already early histological studies of brain tissue from AD patients were able to reveal neuronal loss, shrinkage of dendritic trees and a decrease in the density of synapses [94] [95] [96] [97] [98] . Further studies in mutant mice have shown that elevated A␤ levels result in spine loss [17, [99] [100] [101] , reduction in the number of excitatory synapses [102] and depressed glutamatergic synaptic transmission [103, 104] accompanied by glutamate receptor endocytosis [104, 105] . In cultured cortical neurons, application of A␤ induced internalization of NMDA receptors [105] , whereas A␤ overexpression in organotypic hippocampal slices promoted AMPA receptor removal followed by the loss of dendritic spines and NMDA responses [104] . In double knock-in mice carrying human mutations in the genes for APP and PS1, only AMPA receptors were down-regulated, while NMDA receptors remained unaffected [106] . In agreement with these data, electrophysiological studies of triple transgenic mice harbouring PS1M146V, APPSwe and tauP301L [107] [89] . Further studies have shown that (i ) increased resting Ca 2ϩ concentration in neurites [88] , (ii ) synaptically driven neuronal hyperactivity [90] , (iii ) initiation of intercellular Ca 2ϩ waves in astrocytes [91] and (iv) the already mentioned loss of dendritic spines [101] and excitatory synapses [102] are predominantly observed in close proximity to amyloid plaques (Fig. 2) [127] . Each of these factors may, alone or in concert, contribute to cellular/network dysfunction in the plaque vicinity.
Interestingly, a recent in vivo study has shown that acute application of lipopolysaccharides (the major toxins of gram-negative bacteria inducing inflammatory response in the central nervous system (for review see [128] )) induces aberrant neuronal activity in the rat somatosensory cortex [129] (Fig. 2) 
